3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Prostatic Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Weight Loss
1
Triple Negative Breast Neoplasms
1
Sleep Apnea Syndromes
1
Sezary Syndrome
1
Sarcoma
1
Overweight
1
Obesity, Morbid
1
Obesity
1
Non-Muscle Invasive Bladder Neoplasms
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Hypertension
1
Hyperlipidemias
1
Hemangioma
1
Gastroesophageal Reflux
1
Eczema
1
Digestive System Diseases
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Dermatitis, Atopic
1
Collagen Diseases
1
Breast Neoplasms
1
Interventions
Gene Expression Profiling
9
Surveys and Questionnaires
7
Blood Specimen Collection
7
Surgical Procedures, Operative
6
Polymerase Chain Reaction
6
Microarray Analysis
4
Immunohistochemistry
4
Base Sequence
4
Trabectedin
3
Therapeutics
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation
3
Psychiatric Rehabilitation
3
Observation
3
Drug Therapy
3
Radiotherapy
2
Patient Reported Outcome Measures
2
Molecular Diagnostic Techniques
2
Methods
2
In Situ Hybridization, Fluorescence
2
Gene Rearrangement
2
DNA Methylation
2
Amplified Fragment Length Polymorphism Analysis
2
trastuzumab deruxtecan
1
pazopanib
1
liposomal doxorubicin
1
fluorodopa F 18
1
eribulin
1
Watchful Waiting
1
Urine Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Sarcoma
×
Urine Specimen Collection
×
Clear all
NCT06482957
2025-09-19
CAUSAL
Vanderbilt-Ingram Cancer Center
Recruiting
2,100 enrolled